封面
市場調查報告書
商品編碼
1427182

全球眼保健補充品市場規模、佔有率、成長分析(按成分類型、適應症、劑型)- 2023-2030 年產業預測

Global Eye Health Supplements Market Size, Share, Growth Analysis, By Ingredient Type(Lutein and Zeaxanthin, Antioxidants), By Indication(Age-related Macular Degeneration (AMD), Cataract), By Formulation(Tablets, Capsules)-Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球眼保健補充品市場規模預估為17.9億美元,從2023年的19億美元成長到2031年的30億美元,預測期間(2024-2031年)複合年成長率為5.9%。成長為美元。

眼保健產品市場正在經歷各種因素的顯著成長,例如視力障礙和近視患病率的增加,以及由於螢幕使用和線上互動(尤其是在家工作時)增加而導致的 COVID-19 爆發。近視度數的快速增加與白內障、青光眼和老齡化黃斑部病變等進行性眼科疾病的風險增加有關。這一趨勢導致容易受到數位眼疲勞和近視影響的老年人和千禧世代對眼保健產品的需求不斷成長,從而促進了全球市場的擴張。各種眼科疾病的流行,如老齡化黃斑部病變(AMD)、乾眼症、白內障和發炎,以及眼科醫生建議使用眼部保健補充品來預防和治療這些疾病,正在推動市場的成長,我們正在進一步推動。世界衛生組織 (WHO) 報告稱,全球約有 22 億人患有視力喪失或失明,低收入和中等收入國家的盛行率明顯高於高所得國家。尤其是在貧窮國家,女性更容易患上白內障和AMD等眼科疾病。美國、加拿大、澳洲和英國等新興國家在包括眼部保健補充食品在內的醫療保健品上的人均支出較高,有助於市場擴張。對含有葉黃素和玉米黃質以及越橘萃取物以促進眼睛健康的補充品的需求不斷成長,加上透過直銷和電子商務平台輕鬆獲得,進一步推動了市場成長。此外,旨在滿足全球 10 億未經治療的視障殘障人士需求的新型眼保健補充品的推出預計將為市場注入活力。例如,博士倫於2020年在美國推出了PreserVision AREDS 2 Formula微凝膠眼科維生素,與該公司傳統的軟膠囊配方相比,為晚期AMD患者提供了更方便的選擇。這些補充品強大的銷售管道和供應網路也為市場擴張做出了重大貢獻。 NutraIngredients 的研究顯示,近幾個月來,眼保健補充品的網路零售大幅成長約 48.3%,而新冠肺炎 (COVID-19) 危機是造成這種成長的原因之一。這凸顯了市場的彈性和適應性,為不久的將來的進一步成長鋪平了道路。

自上而下和自下而上的方法已用於估計和檢驗全球眼保健補充品市場規模,並估計其他各個相關子市場的規模。用於估計市場規模的調查方法包括以下細節:透過二次研究確定市場的主要企業,並透過初步和二次研究確定每個地區的市場佔有率。整個過程包括研究主要企業的年度報告和財務報告,以及廣泛的採訪,以獲取首席執行官、副總裁、董事和行銷負責人等行業領導者的關鍵見解。馬蘇。所有股份比率和細分均使用二手資訊確定並使用主要資訊檢驗。對本研究涵蓋的所有可能影響市場的參數進行了解釋,查看了廣泛的詳細資訊,並通過初步研究檢驗和分析,以獲得最終的定量和定性資料。

眼保健補充品全球市場區隔分析

全球眼保健補充品市場按成分類型、適應症、配方和地區細分。根據成分類型,市場分為葉黃素和玉米黃質、抗氧化劑、 Omega-3脂肪酸、Coenzyme Q10、類黃酮、α-硫辛酸、蝦青素和其他補充品。根據跡象,市場分為老齡化黃斑部病變(AMD)、白內障、乾眼症、發炎等。依配方分類,市場分為錠劑、膠囊、粉末、軟膠囊和液體。按地區分類,全球眼保健補充品市場分為北美、歐洲、亞太地區、南美洲和中東和非洲。

眼保健補充品的全球市場促進因素

老齡化黃斑部病變(AMD)、白內障和乾眼症等與眼睛相關的疾病的增加增加了對眼睛保健補充品的需求。隨著世界人口老化的增加,這些疾病的盛行率預計將上升,為促進和維持最佳眼睛健康的補充品創造一個不斷成長的市場。

全球眼保健補充品市場的限制因素

儘管有軼事證據和早期研究表明眼睛保健補充品具有積極作用,但有關其有效性和長期影響的整體科學證據有限。缺乏全面的臨床研究和標準化調查方法是一個限制因素,可能會削弱消費者對補充品的信任和接受度。

全球眼保健補充品市場趨勢

消費者對維持最佳眼睛健康和預防與老齡化,促使人們採取積極主動的措施。人們正在積極地將眼保健補充品涵蓋他們的整體健康習慣中。

消費者越來越喜歡由天然有機成分製成的眼保健補充品。重點是不含合成添加劑、防腐劑和人工色素的產品。這些趨勢迫使製造商生產具有透明和清潔成分的補充品。

眼部保健補充品現在旨在解決特定的眼部疾病,例如老齡化黃斑部病變(AMD)、白內障、乾眼症和青光眼。製造商根據消費者的具體偏好開發專門的配方,並滿足與這些條件相關的獨特營養需求。

含有維生素、礦物質、抗氧化劑和其他必需營養素的眼部保健補充品越來越受歡迎。這些補充品為整體眼睛健康提供全面支持,並為喜歡單一產品滿足多種營養需求的消費者提供了便利的選擇。

目錄

  • 執行摘要
  • 調查方法
  • 母市場分析
  • 主要市場考察
    • 技術分析
    • 價格分析
    • 供應鏈分析
    • 價值鏈分析
    • 市場生態系統
    • 智慧財產權分析
    • 貿易分析
    • Start-Ups分析
    • 原料分析
    • 創新矩陣
    • 研發線產品分析
    • 總體經濟指標
    • 主要投資分析
    • 關鍵成功因素
    • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
    • 監管形勢
    • 波特的分析
    • 對未來中斷的特殊考慮
  • 全球眼部保健補充品市場:依成分類型
    • 市場概況
    • 葉黃素和玉米黃質
    • 抗氧化劑
    • Omega-3脂肪酸
    • Coenzyme Q10
    • 類黃酮
    • 硫辛酸
    • 蝦青素
    • 和其他補充品
  • 全球眼部保健補充品市場:依適應症分類
    • 市場概況
    • 老齡化黃斑部病變(AMD)
    • 白內障
    • 乾眼症
    • 發炎
    • 其他
  • 全球眼部保健補充品市場:按劑型
    • 市場概況
    • 錠劑
    • 膠囊
    • 粉末
    • 軟凝膠
    • 液體
  • 全球眼保健補充品市場規模:依地區分類
    • 市場概況
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
      • 德國
      • 西班牙
      • 法國
      • 英國
      • 其他歐洲國家地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 拉丁美洲
      • 巴西
      • 其他拉丁美洲地區
    • 中東和非洲 (MEA)
      • 海灣合作理事會國家
      • 南非
      • 其他中東/非洲地區
  • 競爭形勢
    • 前5名企業對比
    • 主要企業市場定位(2021年)
    • 主要市場參與者所採取的策略
    • 關鍵成功策略
    • 近期市集活動
    • 主要企業市場佔有率(2021年)
  • 主要企業簡介
    • Bausch Health Companies Inc.
    • Vitabiotics Ltd.
    • Novartis International AG
    • Alcon Inc.
    • The Nature's Bounty Co.
    • Pfizer Inc.
    • Amway Corporation
    • ZeaVision Holdings, Inc.
    • Valeant Pharmaceuticals International, Inc.
    • Swanson Health Products, Inc.
    • GNC Holdings Inc.
    • Nature's Way Products, LLC
    • EyePromise
    • The Himalaya Drug Company
    • Nutraceutical Corporation
    • Vitafusion
    • EyeScience Labs, LLC
    • NOW Foods
    • Ocuvite(Abbott Laboratories)
    • Carlson Labs
簡介目錄
Product Code: SQMIG35I2201

Global Eye Health Supplements Market size was valued at USD 1.79 Billion in 2022 and is poised to grow from USD 1.9 Billion in 2023 to USD 3.00 Billion by 2031, at a CAGR of 5.9% during the forecast period (2024-2031).

The market for eye health products is witnessing significant growth, propelled by various factors such as the increasing incidence of vision impairment and myopic vision, particularly during the COVID-19 pandemic due to heightened screen usage and online interactions while working from home. The surge in myopia is linked to a higher risk of developing progressive eye conditions like cataracts, glaucoma, and age-related macular degeneration. This trend has led to a heightened demand for eye health products among both elderly individuals and millennials, who are susceptible to digital eye fatigue and myopia, contributing to global market expansion. The prevalence of various eye conditions, including Age-related Macular Degeneration (AMD), dry eye syndrome, cataracts, and inflammation, along with endorsements from ophthalmologists for the use of eye health supplements in preventing and treating these disorders, is further driving market growth. The World Health Organization (WHO) reports that approximately 2.2 billion people worldwide suffer from vision impairment or blindness, with low and middle-income countries experiencing significantly higher rates than high-income countries. Women, especially in poorer nations, are more likely to be affected by eye diseases such as cataracts and AMD. In developed countries like the United States, Canada, Australia, and the United Kingdom, high per-capita expenditures on healthcare items, including eye health dietary supplements, are contributing to market expansion. The increasing demand for supplements containing Lutein & Zeaxanthin and bilberry extract for promoting eye wellness, coupled with easy accessibility through direct sales and e-commerce platforms, is further fueling market growth. Moreover, the market is expected to experience a boost with the introduction of new eye health supplements aimed at meeting the needs of the 1.0 billion untreated individuals with vision impairment worldwide. For instance, Bausch + Lomb launched its PreserVision AREDS 2 Formula micro gel eye vitamins in the United States in 2020, providing a more convenient option for individuals with advanced AMD compared to the company's previous soft gel formula. The robust sales channels and supply networks for these supplements also contribute significantly to market expansion. A NutraIngredients survey reveals a substantial increase in internet sales of eye health supplements, rising to approximately 48.3% in recent months, driven in part by the COVID-19 crisis. This emphasizes the resilience and adaptability of the market, paving the way for further growth in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Eye Health Supplements Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Eye Health Supplements Market Segmental Analysis

The global eye health supplements Market is segmented into ingredient type, indication, formulation and region. Based on ingredient type, the market is segmented into lutein and zeaxanthin, antioxidants, omega-3 fatty acids, coenzyme Q10, flavonoids, alpha-lipoic acid, astaxanthin, and other supplements. Based on indication, the market is segmented into age-related macular degeneration (AMD), cataract, dry eye syndrome, inflammation, and others. Based on formulation, the market is segmented into tablets, capsules, powder, softgels, liquid. Based on region, the global Eye Health Supplements Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Eye Health Supplements Market

The increasing occurrence of eye-related conditions like age-related macular degeneration (AMD), cataracts, and dry eye syndrome is fueling the need for eye health supplements. With a rising global aging population, the prevalence of these disorders is anticipated to climb, generating an expanding market for supplements designed to promote and maintain optimal eye health.

Restraints in the Global Eye Health Supplements Market

Although there is anecdotal evidence and initial studies suggesting the positive effects of eye health supplements, the overall scientific evidence regarding their effectiveness and long-term impact is constrained. The absence of comprehensive clinical studies and standardized research methodologies serves as a limitation, potentially undermining consumer confidence and acceptance of these supplements.

Market Trends of the Global Eye Health Supplements Market

A rising awareness among consumers regarding the significance of maintaining optimal eye health and preventing age-related eye conditions is prompting a proactive approach. Individuals are actively incorporating eye health supplements into their overall wellness routines.

Consumers are showing a growing preference for eye health supplements crafted from natural and organic ingredients. The emphasis is on products devoid of synthetic additives, preservatives, and artificial colors. This inclination is compelling manufacturers to create supplements with transparent and clean ingredient profiles.

Eye health supplements are now being designed to address particular eye conditions like age-related macular degeneration (AMD), cataracts, dry eye syndrome, and glaucoma. Manufacturers are developing specialized formulations tailored to meet the unique nutritional requirements associated with these conditions, aligning with the specific preferences of consumers.

Combination eye health supplements, encompassing a blend of vitamins, minerals, antioxidants, and other essential nutrients, are gaining traction. These supplements provide comprehensive support for overall eye health, offering a convenient option for consumers who prefer a single product addressing multiple nutritional needs.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
    • Regulatory Landscape
    • Porters Analysis
      • Competitive rivalry
      • Threat of Substitute Products
      • Bargaining Power of Buyers
      • Threat of New Entrants
      • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
      • Political Impact
      • Economic Impact
      • Social Impact
      • Technical Impact
      • Environmental Impact
      • Legal Impact
  • Global Eye Health Supplements Market by Ingredient Type
    • Market Overview
    • Lutein and Zeaxanthin
    • Antioxidants
    • Omega-3 Fatty acids
    • Coenzyme Q10
    • Flavonoids
    • Alpha-Lipoic Acid
    • Astaxanthin
    • and Other Supplements
  • Global Eye Health Supplements Market by Indication
    • Market Overview
    • Age-related Macular Degeneration (AMD)
    • Cataract
    • Dry Eye Syndrome
    • Inflammation
    • and Others
  • Global Eye Health Supplements Market by Formulation
    • Market Overview
    • Tablets
    • Capsules
    • Powder
    • Softgels
    • Liquid
  • Global Eye Health Supplements Market Size by Region
    • Market Overview
    • North America
      • USA
      • Canada
    • Europe
      • Germany
      • Spain
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC Countries
      • South Africa
      • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
      • By Development
      • By Company
      • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Bausch Health Companies Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Vitabiotics Ltd.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Novartis International AG
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Alcon Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • The Nature's Bounty Co.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Pfizer Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Amway Corporation
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • ZeaVision Holdings, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Valeant Pharmaceuticals International, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Swanson Health Products, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • GNC Holdings Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Nature's Way Products, LLC
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • EyePromise
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • The Himalaya Drug Company
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Nutraceutical Corporation
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Vitafusion
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • EyeScience Labs, LLC
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • NOW Foods
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Ocuvite (Abbott Laboratories)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Carlson Labs
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments